These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9777922)

  • 21. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: a progress report. How far the search for treatments has come and where it is heading.
    Harv Ment Health Lett; 2003 Nov; 20(5):1-4. PubMed ID: 14633486
    [No Abstract]   [Full Text] [Related]  

  • 23. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotheraphy for Alzheimer's disease.
    Knopman D
    Curr Neurol Neurosci Rep; 2001 Sep; 1(5):428-34. PubMed ID: 11898553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatments for Alzheimer disease.
    Potyk D
    South Med J; 2005 Jun; 98(6):628-35. PubMed ID: 16004170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
    Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
    Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological treatment].
    Arriola Manchola E; Álaba Trueba J
    Rev Esp Geriatr Gerontol; 2016 Jun; 51 Suppl 1():22-26. PubMed ID: 27719968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapeutics for Alzheimer's disease: an avenue of hope.
    Samuels SC; Grossman H
    CNS Spectr; 2003 Nov; 8(11):834-45. PubMed ID: 14702006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alzheimer's disease].
    Jedidi H; Jedidi Z; Salmon E
    Rev Med Liege; 2010 Mar; 65(3):163-8. PubMed ID: 20411822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Alzheimer's disease. Promising advances in detection and treatment.
    Burke JR; Morgenlander JC
    Postgrad Med; 1999 Oct; 106(5):85-6, 89-90, 93-4 passim. PubMed ID: 10560470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.
    Nasab NM; Bahrammi MA; Nikpour MR; Rahim F; Naghibis SN
    J Pak Med Assoc; 2012 Jul; 62(7):677-80. PubMed ID: 23866514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Alzheimer's disease.
    Cummings JL
    Clin Cornerstone; 2001; 3(4):27-39. PubMed ID: 11432120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in the management of Alzheimer's disease.
    Smith AL; Whitehouse PJ
    Hosp Pract (1995); 1998 Mar; 33(3):151-4, 157-66. PubMed ID: 9522840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacological management of cognitive dysfunction in Alzheimer's disease.
    Vandewoude MF
    Acta Clin Belg; 1999 Oct; 54(5):306-11. PubMed ID: 10555391
    [No Abstract]   [Full Text] [Related]  

  • 39. An update on primary drug therapies for Alzheimer disease.
    Knopman DS; Morris JC
    Arch Neurol; 1997 Nov; 54(11):1406-9. PubMed ID: 9362990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative drug therapies for dementia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.